Bupivacaine local infiltration at trocar insertion sites after gynecologic laparoscopic surgery: A randomized, double-blind, placebo-controlled clinical trial
Phase 4
- Conditions
- Bupivacaine local infiltration at trocar insertion sites after gynecologic laparoscopic surgery control pain decrease pain score than salineGynecologic Laparoscopic Surgery, postoperative pain, bupivacaine
- Registration Number
- TCTR20210904001
- Lead Sponsor
- Obstetrics gynecologic department
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Enrolling by invitation
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
1. Female who has gynecologic laparoscopic surgery with 4-port entry
2. Can listening and reading Thai language
3. Thai nationality
4. No history of bupivacaine allergy or local anesthetic. Allergy
5. No psychiatric disorder
6. No history of medication for control pain in 1 week before
7. Accepted to volunteer in this research project
Exclusion Criteria
1. Female who has gynecologic laparoscopic surgery with port entry less than 4 ports site
2. Who have change laparoscopic surgery convert to laparotomy
3. Volunteers who can leave from journal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative pain At 2,4,8,12,24 hours after intervention Record pain score 0-10 In postoperative at 2,4,8,12,24 hours after surgery ( abdominal pariatal pain, abdominal visceral pain, left shoulder pain , right shoulder pain
- Secondary Outcome Measures
Name Time Method umber of opioid use 72 hour after surgery Number of patient who have opioid use and amount of opioid in patients use ,Adverse effect of bupivacaine 72 hours af surgery Such as : skin rash, seizure, Nausea, Headache, Dizziness, Slow heart rate, Blurred vision ,hearing loss